CN104087681A - 利用基因芯片检测小檗碱诱导RMMVECs基因表达谱的方法 - Google Patents
利用基因芯片检测小檗碱诱导RMMVECs基因表达谱的方法 Download PDFInfo
- Publication number
- CN104087681A CN104087681A CN201410369360.9A CN201410369360A CN104087681A CN 104087681 A CN104087681 A CN 104087681A CN 201410369360 A CN201410369360 A CN 201410369360A CN 104087681 A CN104087681 A CN 104087681A
- Authority
- CN
- China
- Prior art keywords
- mix
- rmmvecs
- gene
- add
- purifying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 71
- 230000014509 gene expression Effects 0.000 title claims abstract description 68
- 238000000034 method Methods 0.000 title claims abstract description 59
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 title claims abstract description 14
- 229940093265 berberine Drugs 0.000 title claims abstract description 14
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 title claims abstract description 14
- 210000004027 cell Anatomy 0.000 claims abstract description 43
- 210000004925 microvascular endothelial cell Anatomy 0.000 claims abstract description 3
- 239000000203 mixture Substances 0.000 claims description 84
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 48
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 32
- 239000000523 sample Substances 0.000 claims description 32
- 238000006243 chemical reaction Methods 0.000 claims description 30
- 238000009396 hybridization Methods 0.000 claims description 28
- 238000010839 reverse transcription Methods 0.000 claims description 25
- 239000007788 liquid Substances 0.000 claims description 24
- 238000002360 preparation method Methods 0.000 claims description 21
- 239000002299 complementary DNA Substances 0.000 claims description 19
- 239000000243 solution Substances 0.000 claims description 19
- 238000005406 washing Methods 0.000 claims description 19
- 239000006228 supernatant Substances 0.000 claims description 17
- 239000006210 lotion Substances 0.000 claims description 15
- 238000001556 precipitation Methods 0.000 claims description 13
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 12
- 230000008859 change Effects 0.000 claims description 10
- 102000004190 Enzymes Human genes 0.000 claims description 9
- 108090000790 Enzymes Proteins 0.000 claims description 9
- 238000000338 in vitro Methods 0.000 claims description 9
- 238000013518 transcription Methods 0.000 claims description 9
- 230000035897 transcription Effects 0.000 claims description 9
- 230000002068 genetic effect Effects 0.000 claims description 8
- 238000005336 cracking Methods 0.000 claims description 7
- 238000001514 detection method Methods 0.000 claims description 7
- 230000003020 moisturizing effect Effects 0.000 claims description 7
- 239000000047 product Substances 0.000 claims description 7
- 239000006059 cover glass Substances 0.000 claims description 6
- 238000000746 purification Methods 0.000 claims description 6
- 239000013614 RNA sample Substances 0.000 claims description 5
- 230000009514 concussion Effects 0.000 claims description 5
- 238000007405 data analysis Methods 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 5
- 230000006698 induction Effects 0.000 claims description 5
- -1 methane amide Chemical class 0.000 claims description 5
- 238000007710 freezing Methods 0.000 claims description 4
- 230000008014 freezing Effects 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 238000011068 loading method Methods 0.000 claims description 4
- 210000004165 myocardium Anatomy 0.000 claims description 4
- 238000010791 quenching Methods 0.000 claims description 4
- 230000000171 quenching effect Effects 0.000 claims description 4
- 239000000376 reactant Substances 0.000 claims description 4
- 241000208340 Araliaceae Species 0.000 claims description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 3
- 101710163270 Nuclease Proteins 0.000 claims description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 3
- 238000013019 agitation Methods 0.000 claims description 3
- 238000007621 cluster analysis Methods 0.000 claims description 3
- 238000004090 dissolution Methods 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 3
- 230000003828 downregulation Effects 0.000 claims description 3
- 235000008434 ginseng Nutrition 0.000 claims description 3
- 230000036571 hydration Effects 0.000 claims description 3
- 238000006703 hydration reaction Methods 0.000 claims description 3
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims description 3
- 235000008476 powdered milk Nutrition 0.000 claims description 3
- 238000004321 preservation Methods 0.000 claims description 3
- 239000012264 purified product Substances 0.000 claims description 3
- 102000004594 DNA Polymerase I Human genes 0.000 claims description 2
- 108010017826 DNA Polymerase I Proteins 0.000 claims description 2
- 239000011259 mixed solution Substances 0.000 claims description 2
- 238000005516 engineering process Methods 0.000 abstract description 11
- 230000035790 physiological processes and functions Effects 0.000 abstract description 9
- 201000010099 disease Diseases 0.000 abstract description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 6
- 239000003814 drug Substances 0.000 abstract description 6
- 238000012258 culturing Methods 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 5
- 230000006378 damage Effects 0.000 abstract description 4
- 230000028327 secretion Effects 0.000 abstract description 4
- 210000002889 endothelial cell Anatomy 0.000 abstract description 2
- 230000002107 myocardial effect Effects 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 239000001963 growth medium Substances 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 238000012423 maintenance Methods 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 230000000283 vasomotion Effects 0.000 abstract 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 23
- 238000012360 testing method Methods 0.000 description 16
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 15
- 230000006870 function Effects 0.000 description 15
- 230000001105 regulatory effect Effects 0.000 description 15
- 230000004060 metabolic process Effects 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 10
- 230000010261 cell growth Effects 0.000 description 9
- 108020004414 DNA Proteins 0.000 description 8
- 210000003989 endothelium vascular Anatomy 0.000 description 8
- 238000012797 qualification Methods 0.000 description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical group [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 7
- 229910052791 calcium Inorganic materials 0.000 description 7
- 239000011575 calcium Substances 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 102000004127 Cytokines Human genes 0.000 description 6
- 108090000695 Cytokines Proteins 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- 238000010348 incorporation Methods 0.000 description 6
- 230000002103 transcriptional effect Effects 0.000 description 6
- 238000000018 DNA microarray Methods 0.000 description 5
- 230000004543 DNA replication Effects 0.000 description 5
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 5
- 102000043136 MAP kinase family Human genes 0.000 description 5
- 108091054455 MAP kinase family Proteins 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 210000004204 blood vessel Anatomy 0.000 description 5
- 230000023852 carbohydrate metabolic process Effects 0.000 description 5
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000004475 Arginine Substances 0.000 description 4
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 4
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 4
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 4
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 4
- 230000001464 adherent effect Effects 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 230000001595 contractor effect Effects 0.000 description 4
- 230000009762 endothelial cell differentiation Effects 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 230000037361 pathway Effects 0.000 description 4
- 239000008279 sol Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 108010047303 von Willebrand Factor Proteins 0.000 description 4
- 102100036537 von Willebrand factor Human genes 0.000 description 4
- 102000007469 Actins Human genes 0.000 description 3
- 108010085238 Actins Proteins 0.000 description 3
- 101100059544 Arabidopsis thaliana CDC5 gene Proteins 0.000 description 3
- 101100244969 Arabidopsis thaliana PRL1 gene Proteins 0.000 description 3
- 102100040428 Chitobiosyldiphosphodolichol beta-mannosyltransferase Human genes 0.000 description 3
- 102100032369 Coiled-coil domain-containing protein 112 Human genes 0.000 description 3
- 102100036763 Extended synaptotagmin-1 Human genes 0.000 description 3
- 102100039558 Galectin-3 Human genes 0.000 description 3
- 101100059310 Homo sapiens CCDC112 gene Proteins 0.000 description 3
- 101000891557 Homo sapiens Chitobiosyldiphosphodolichol beta-mannosyltransferase Proteins 0.000 description 3
- 101000851525 Homo sapiens Extended synaptotagmin-1 Proteins 0.000 description 3
- 101100454448 Homo sapiens LGALS3 gene Proteins 0.000 description 3
- 101150022168 L3MBTL3 gene Proteins 0.000 description 3
- 101100237293 Leishmania infantum METK gene Proteins 0.000 description 3
- 102100040548 Lethal(3)malignant brain tumor-like protein 3 Human genes 0.000 description 3
- 101150115300 MAC1 gene Proteins 0.000 description 3
- 101150051246 MAC2 gene Proteins 0.000 description 3
- 101150108651 MAT2 gene Proteins 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000033115 angiogenesis Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004292 cytoskeleton Anatomy 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 230000003511 endothelial effect Effects 0.000 description 3
- 210000003725 endotheliocyte Anatomy 0.000 description 3
- 239000007850 fluorescent dye Substances 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000007923 virulence factor Effects 0.000 description 3
- 239000000304 virulence factor Substances 0.000 description 3
- 108020004463 18S ribosomal RNA Proteins 0.000 description 2
- 108010067225 Cell Adhesion Molecules Proteins 0.000 description 2
- 101100076569 Euplotes raikovi MAT3 gene Proteins 0.000 description 2
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 2
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 102000008299 Nitric Oxide Synthase Human genes 0.000 description 2
- 108010021487 Nitric Oxide Synthase Proteins 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- QMNWISYXSJWHRY-YLNUDOOFSA-N astragaloside IV Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)[C@H]4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)C[C@H]3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-YLNUDOOFSA-N 0.000 description 2
- 230000001851 biosynthetic effect Effects 0.000 description 2
- 102000008395 cell adhesion mediator activity proteins Human genes 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- PFKIBRPYVNVMRU-UHFFFAOYSA-N cyclosieversioside F Natural products CC(C)(O)C1COC(C)(C1)C2C(O)CC3(C)C4CC(OC5OC(CO)C(O)C(O)C5O)C6C(C)(C)C(CCC67CC47CCC23C)OC8OCC(O)C(O)C8O PFKIBRPYVNVMRU-UHFFFAOYSA-N 0.000 description 2
- IWUMQCYNYDYUKR-UHFFFAOYSA-N cyclosiversioside F Natural products CC(C)(O)C1CCC(C)(O1)C2C(O)CC3C4CC(OC5OC(CO)C(O)C(O)C5O)C6C(C)(C)C(CCC67CC47CCC23C)OC8OCC(O)C(O)C8O IWUMQCYNYDYUKR-UHFFFAOYSA-N 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000003365 immunocytochemistry Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 230000022558 protein metabolic process Effects 0.000 description 2
- 230000017854 proteolysis Effects 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 230000019491 signal transduction Effects 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 108091006106 transcriptional activators Proteins 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 210000003556 vascular endothelial cell Anatomy 0.000 description 2
- 101150012728 Adcy8 gene Proteins 0.000 description 1
- 101150106195 BACE2 gene Proteins 0.000 description 1
- 101100298998 Caenorhabditis elegans pbs-3 gene Proteins 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 101150096910 Chst7 gene Proteins 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 244000247747 Coptis groenlandica Species 0.000 description 1
- 235000002991 Coptis groenlandica Nutrition 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 101150049876 EDN1 gene Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 206010048554 Endothelial dysfunction Diseases 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 101150113031 Jag1 gene Proteins 0.000 description 1
- 101150004048 MIPEP gene Proteins 0.000 description 1
- 101150037751 MYH9 gene Proteins 0.000 description 1
- 108700006416 NBPhox Proteins 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 description 1
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 description 1
- 101150038322 Phkg2 gene Proteins 0.000 description 1
- 101150065560 Prss30 gene Proteins 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 101150063416 add gene Proteins 0.000 description 1
- 102000011759 adducin Human genes 0.000 description 1
- 108010076723 adducin Proteins 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000003570 biosynthesizing effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004782 brain capillary endothelium Anatomy 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 239000002771 cell marker Substances 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 210000001174 endocardium Anatomy 0.000 description 1
- 230000008694 endothelial dysfunction Effects 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000006377 glucose transport Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 101150056639 rasl11b gene Proteins 0.000 description 1
- 230000029865 regulation of blood pressure Effects 0.000 description 1
- 230000026267 regulation of growth Effects 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
组分名称 | 体积 |
First Strand Bμffer Mix | 4μL |
First Strand Enzyme Mix | 1μL |
组分名称 | 体积 |
Nμclease-free Water | 13μL |
Second-strand Bμffer Mix | 5μL |
Second-strand Enzyme Mix | 2μL |
组分名称 | 体积 |
Nμclease-free Water | 4μL |
T7 Bμffer Mix | 20μL |
T7 Enzyme Mix | 6L |
组分名称 | 体积 |
4×CbcScriptⅡ Bμffer | 5μL |
0.1M DTT | 2μL |
CbcScriptⅡ | 1.5μL |
组分名称 | 体积 |
5×Klenow Bμffer | 5μL |
Klenow Fragment | 1.2μL |
组分 | 体积μL |
甲酰胺 | 20 |
20*SSC | 12 |
10*SDS | 1.6 |
50*Dehart | 8μL |
样品名 | 浓度μg/μl | 260/280 | 样品名 | 浓度 | 260/280 |
MAC1 | 0.7235 | 1.98 | MAT1 | 0.5904 | 1.96 |
MAC2 | 0.8391 | 2.03 | MAT2 | 0.7857 | 1.99 |
MAC3 | 0.6896 | 1.99 | MAT3 | 0.6613 | 1.96 |
MBC1 | 0.5656 | 1.94 | MBT1 | 0.6439 | 1.99 |
MBC2 | 0.5482 | 1.98 | MBT2 | 0.7959 | 2.04 |
MBC3 | 0.6553 | 2.03 | MBT3 | 0.5970 | 2.01 |
样品名 | 纯化后RNA | 纯化后cRNA | cDNA | 荧光掺入量 | 样品名 | 纯化后RNA | 纯化后cRNA | cDNA | 荧光掺入量 |
MAC1 | 230.8 | 0.9369 | 295.6 | 3.8 | MAT1 | 189.3 | 0.6674 | 183.4 | 3.1 |
MAC2 | 154.2 | 0.9732 | 247.8 | 3.4 | MAT2 | 178.4 | 0.4756 | 100.6 | 4.7 |
MAC3 | 143.6 | 0.8654 | 209.8 | 2.8 | MAT3 | 146.8 | 0.3272 | 130.2 | 4.1 |
MBC1 | 187.6 | 0.3546 | 118.5 | 3.1 | MBT1 | 189.4 | 0.4721 | 166.3 | 5.1 |
MBC2 | 125.5 | 0.3172 | 127.9 | 4.5 | MBT2 | 220.3 | 0.6932 | 159.4 | 2.8 |
MBC3 | 123.7 | 0.2947 | 179.8 | 3.8 | MBT3 | 135.3 | 0.5453 | 171.3 | 2.6 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410369360.9A CN104087681B (zh) | 2014-04-23 | 2014-07-30 | 利用基因芯片检测小檗碱诱导RMMVECs基因表达谱的方法 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410164488.1 | 2014-04-23 | ||
CN2014101644881 | 2014-04-23 | ||
CN201410164488 | 2014-04-23 | ||
CN201410369360.9A CN104087681B (zh) | 2014-04-23 | 2014-07-30 | 利用基因芯片检测小檗碱诱导RMMVECs基因表达谱的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104087681A true CN104087681A (zh) | 2014-10-08 |
CN104087681B CN104087681B (zh) | 2016-05-25 |
Family
ID=51635439
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410369360.9A Active CN104087681B (zh) | 2014-04-23 | 2014-07-30 | 利用基因芯片检测小檗碱诱导RMMVECs基因表达谱的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104087681B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108949912A (zh) * | 2018-07-23 | 2018-12-07 | 北京农学院 | 一种利用基因芯片检测α-倒捻子素引发的基因表达变化的方法 |
-
2014
- 2014-07-30 CN CN201410369360.9A patent/CN104087681B/zh active Active
Non-Patent Citations (4)
Title |
---|
周秋丽等主编: "《现代中药基础研究与临床》", 30 June 2012, article "黄连", pages: 1138-1139 * |
段慧琴等: "小檗碱、白头翁素对肠黏膜微血管内皮E-selectin表达的影响", 《黑龙江畜牧兽医》, vol. 11, 31 December 2011 (2011-12-31), pages 8 - 10 * |
祁冰等: "基因芯片研究小檗碱对胰岛素抵抗卵巢颗粒细胞基因表达的影响", 《科技导报》, vol. 26, no. 23, 31 December 2008 (2008-12-31), pages 70 - 73 * |
索占伟等: "小檗碱对大鼠肠黏膜微血管内皮细胞分泌一氧化氮的影响", 《中国中西医结合杂志》, vol. 9, 31 December 2007 (2007-12-31), pages 832 - 834 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108949912A (zh) * | 2018-07-23 | 2018-12-07 | 北京农学院 | 一种利用基因芯片检测α-倒捻子素引发的基因表达变化的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104087681B (zh) | 2016-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106916781A (zh) | 一种体外三维人体肝组织的构建方法及其应用 | |
CN105779386B (zh) | 一种间充质干细胞在制备治疗m5型白血病药物中的应用 | |
US11608502B2 (en) | RNAi nano-preparation, preparation method thereof and application thereof in TMV prevention and control | |
CN107881241A (zh) | 基因标志物在乳腺癌诊断和治疗中的应用 | |
CN108486060A (zh) | 一种用于治疗肿瘤的外泌体及其制备方法和应用 | |
CN106282347A (zh) | HoxC11作为生物标志物在制备肺腺癌的预诊断试剂中的应用 | |
CN107663539A (zh) | 环状RNA circ‑PTGR1的用途 | |
CN108753776A (zh) | 一种参与鸡肌肉生长发育的环状RNA circGHR及检测引物 | |
CN107419004A (zh) | lncRNA‑RP11‑290F20.3及其小干扰RNA的应用 | |
CN102732484B (zh) | 一种人鼻咽癌肿瘤干细胞系建立方法 | |
CN107604058A (zh) | piRNA‑514核苷酸类似物及其反义核苷酸的应用和应用其的产品 | |
CN107190052A (zh) | Loc101928926基因的用途 | |
CN110229901A (zh) | 与三阴性乳腺癌诊疗相关的基因hsa_circ_0027089及其应用 | |
CN106929577A (zh) | 一种与肺腺癌相关的lncRNA生物标志物 | |
CN104087682A (zh) | 利用基因芯片检测黄芪甲苷诱导RMMVECs基因表达谱的方法 | |
CN107190005B (zh) | lncRNA作为生物标志物在肺腺癌诊治中的应用 | |
CN109055561A (zh) | lncRNA-AP003774.1在诊断和/或治疗乳腺癌症中的应用 | |
CN105886507B (zh) | 长链非编码rna fam83h-as1在制备治疗非小细胞肺癌药物中的应用 | |
CN108085389A (zh) | 一种与乳腺癌相关的lncRNA及其应用 | |
CN104087681B (zh) | 利用基因芯片检测小檗碱诱导RMMVECs基因表达谱的方法 | |
CN110229900A (zh) | 与乳腺癌诊疗相关的基因hsa_circ_0103520及其应用 | |
CN106729756A (zh) | 生物标志物作为靶标在肺腺癌诊治中的应用 | |
CN108465108A (zh) | 一种预防或治疗脑胶质瘤的特异性基因靶点 | |
CN106702002A (zh) | 一种用于肺腺癌诊治的生物标志物 | |
CN103146642A (zh) | 一种定向诱导间充质干细胞分化的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180817 Address after: 102600 Beijing Daxing District biological medicine industrial base Yong 44 Road No. Patentee after: BEIJING CENTRE BIOLOGY Co.,Ltd. Address before: 102200 7 North Agricultural Road, Huilongguan Town, Changping District, Beijing Patentee before: Beijing University Of Agriculture |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200910 Address after: 102600 Beijing Daxing District biological medicine industrial base Yong 44 Road No. Patentee after: Edison (Beijing) Biotechnology Co.,Ltd. Address before: 102600 Beijing Daxing District biological medicine industrial base Yong 44 Road No. Patentee before: BEIJING CENTRE BIOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240725 Address after: 102600 No.44 Yongda Road, Daxing biomedical industrial base, Zhongguancun Science and Technology Park, Daxing District, Beijing Patentee after: BEIJING CENTRE BIOLOGY Co.,Ltd. Country or region after: China Address before: 102600 Beijing Daxing District biological medicine industrial base Yong 44 Road No. Patentee before: Edison (Beijing) Biotechnology Co.,Ltd. Country or region before: China |